lactobacillus reuteri (BGP014) / BioGaia 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lactobacillus reuteri (BGP014) / BioGaia
NCT05118919 / 2019-004578-25: A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis

Recruiting
1/2
50
Europe
BGP-014, Placebo
BioGaia Pharma AB
Ulcerative Colitis
12/23
12/23

Download Options